login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
STANDARD BIOTOOLS INC (LAB) Stock News
USA
- NASDAQ:LAB -
US34385P1084
-
Common Stock
1.19
USD
-0.05 (-4.03%)
Last: 11/4/2025, 8:00:02 PM
1.23
USD
+0.04 (+3.36%)
After Hours:
11/4/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
LAB Latest News, Press Relases and Analysis
All
Press Releases
7 hours ago - By: Standard BioTools Inc.
Standard BioTools Reports Third Quarter 2025 Financial Results
17 hours ago - By: Benzinga
- Mentions:
KURA
SEE
HRMY
FOLD
...
Earnings Scheduled For November 4, 2025
15 days ago - By: Standard BioTools Inc.
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
2 months ago - By: Illumina, Inc.
- Mentions:
ILMN
Lancement d'Illumina® Protein Prep pour améliorer les connaissances protéomiques et faciliter les découvertes et le développement de médicaments
2 months ago - By: Illumina, Inc.
- Mentions:
ILMN
Illumina® Protein Prep, daha iyi ilaç keşfi ve geliştirilmesi için daha fazla proteomik içgörü sağlamak üzere piyasaya sürüldü
2 months ago - By: Illumina, Inc.
- Mentions:
ILMN
Illumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung
6 months ago - By: Benzinga
- Mentions:
ENLT
SSL
ATKR
GPOR
...
Earnings Scheduled For May 6, 2025
a year ago - By: Standard BioTools Inc.
Standard BioTools to Participate in Upcoming Investor Conferences
2 months ago - By: Illumina, Inc.
- Mentions:
ILMN
Se lanza Illumina® Protein Prep para impulsar mayores conocimientos proteómicos
2 months ago - By: Illumina, Inc.
- Mentions:
ILMN
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
3 months ago - By: Zacks Investment Research
- Mentions:
NYXH
Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: Standard BioTools Inc.
Standard BioTools Reports Second Quarter 2025 Financial Results
3 months ago - By: Zacks Investment Research
- Mentions:
DOCS
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
4 months ago - By: Standard BioTools Inc.
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
4 months ago - By: Yahoo Finance
- Mentions:
ILMN
Illumina to Acquire SomaLogic for $350 Million, Expanding into Proteomics and Precision Medicine
4 months ago - By: Illumina, Inc.
- Mentions:
ILMN
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
4 months ago - By: Standard BioTools Inc.
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
4 months ago - By: Yahoo Finance
- Mentions:
ILMN
MSFT
Illumina to buy SomaLogic for up to $425M
5 months ago - By: Standard BioTools Inc.
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series
6 months ago - By: Zacks Investment Research
- Mentions:
SDGR
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: Standard BioTools Inc.
Standard BioTools Reports First Quarter 2025 Financial Results
7 months ago - By: Standard BioTools Inc.
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025
8 months ago - By: Standard BioTools Inc.
Standard BioTools to Participate in Upcoming Investor Conferences
8 months ago - By: Standard BioTools Inc.
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results
10 months ago - By: Standard BioTools Inc.
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
10 months ago - By: Standard BioTools Inc.
Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine
a year ago - By: Standard BioTools Inc.
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
a year ago - By: Standard BioTools Inc.
Standard BioTools Appoints Alex Kim as Chief Financial Officer
a year ago - By: Standard BioTools Inc.
Standard BioTools Reports Third Quarter 2024 Financial Results
a year ago - By: Standard BioTools Inc.
Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024
a year ago - By: Standard BioTools Inc.
Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform
Please enable JavaScript to continue using this application.